Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Episode 31: Intracameral Phenylephrine 1% and Ketorolac 0.3% for Cataract Surgery

Christopher E. Starr, MD, and Eric D. Donnenfeld, MD, discuss Omidria (Omeros), the first intracameral medication approved by the FDA for routine use during cataract surgery. According to Dr. Donnenfeld, this approval represents a disruptive change in ophthalmology and points to the future of the field: drug delivery. He describes the indications for Omidria, how he is using the product in his practice, and the financial implications of this medication.


32 / 62 Series: CRST Journal Club


More Videos in this Series